Advancing LBCL Treatment Through MRD Monitoring and Allogeneic CAR T-Cell Therapy

Retrieved on: 2025-01-22 14:20:47

Tags for this article:

Click the tags to see associated articles and topics

Advancing LBCL Treatment Through MRD Monitoring and Allogeneic CAR T-Cell Therapy. View article details on hiswai:

Excerpt

The addition of anti-CD52 monoclonal antibodies to lymphodepletion may also have a role in enhancing T-cell depletion prior to CAR T-cell infusion.

Article found on: www.pharmacytimes.com